Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study

Cancer Treat Rep. 1982 Jul;66(7):1687-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Drug Evaluation
  • Follow-Up Studies
  • Humans
  • Injections, Intravenous
  • Lymphoma / drug therapy*
  • Maytansine / administration & dosage
  • Maytansine / therapeutic use
  • Maytansine / toxicity*
  • Oxazines / toxicity*

Substances

  • Oxazines
  • Maytansine